Journals / Journal of Urological Surgery / 2019 / Cilt: 6 - Sayı: 3

Fournier’s Gangrene: Analysis of Risk Factors Affecting Mortality in a Tertiary Urology Referral Center

Fournier Gangreni: Tersiyer Bir Üroloji Referans Merkezinde Mortaliteye Etki Eden Risk Faktörlerinin Analizi

Pages
196–200
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mortality rate was 14.6%.Increased age, Fournier’s Gangrene Severity Index (FGSI) scores, prolonged operative time, presence of immunosuppressive diseases, abdominalspread of the disease, history of cystostomy, mechanical ventilation requirement, and multiple micro-organism in wound culture were found to berisk factors for mortality in patients with FG.Conclusion: Increased age, high FGSI scores, increased operative time, presence of immunosuppressive diseases, history of cystostomy, abdominalspread of the disease, mechanical ventilation requirements, and multiple micro-organism in wound culture were thought to affect mortality inpatients with FG.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to investigate the risk factors affecting mortality in patients with Fournier’s gangrene (FG).Materials and Methods: Records of 48 male patients, who were admitted to our urology clinic between November 2011 and June 2018, wereanalyzed.
📊
Key Findings & Data:The patients were divided into two groups according to their survival status. statistical analyses were done to determine the risk factorsfor mortality.Results: The mean age was 53.9±12.61 years. 41 patients were discharged (group 1) and 7 were deceased (group 2).
💡
Conclusion & Impact:The mortality rate was 14.6%.Increased age, Fournier’s Gangrene Severity Index (FGSI) scores, prolonged operative time, presence of immunosuppressive diseases, abdominalspread of the disease, history of cystostomy, mechanical ventilation requirement, and multiple micro-organism in wound culture were found to berisk factors for mortality in patients with FG.Conclusion: Increased age, high FGSI scores, increased operative time, presence of immunosuppressive diseases, history of cystostomy, abdominalspread of the disease, mechanical ventilation requirements, and multiple micro-organism in wound culture were thought to affect mortality inpatients with FG.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to investigate the risk factors affecting mortality in patients with Fournier’s gangrene (FG).Materials and Methods: Records of 48 male patients, who were admitted to our urology clinic between November 2011 and June 2018, wereanalyzed. The patients were divided into two groups according to their survival status. statistical analyses were done to determine the risk factorsfor mortality.Results: The mean age was 53.9±12.61 years. 41 patients were discharged (group 1) and 7 were deceased (group 2). The mortality rate was 14.6%.Increased age, Fournier’s Gangrene Severity Index (FGSI) scores, prolonged operative time, presence of immunosuppressive diseases, abdominalspread of the disease, history of cystostomy, mechanical ventilation requirement, and multiple micro-organism in wound culture were found to berisk factors for mortality in patients with FG.Conclusion: Increased age, high FGSI scores, increased operative time, presence of immunosuppressive diseases, history of cystostomy, abdominalspread of the disease, mechanical ventilation requirements, and multiple micro-organism in wound culture were thought to affect mortality inpatients with FG.

Özet

Amaç: Fournier kangreni (FG) hastalarında mortaliteyi etkileyen risk faktörlerini araştırmayı amaçladık. Gereç ve Yöntem: Kasım 2011 ve Haziran 2018 arasında 48 erkek hastanın kayıtları analiz edildi. Hastalar sağkalım durumlarına göre iki gruba ayrıldı. Mortaliteye etki eden risk faktörlerini belirlemek için istatistiksel analizler yapıldı. Bulgular: Ortalama yaş 53,9±12,61 idi. Hastaların 41’i taburcu olmuş (grup 1) ve 7’si vefat etmişti (grup 2). Mortalite oranı %14,6 idi. Artmış yaş, artmış Fournier Gangreni Severity Indeks (FGSI) skorları, artmış operasyon süresi, immünosüpresyon hastalığı olması, sistostomi yapılması, hastalığın abdominal yayılması, mekanik ventilasyon ihtiyacı, yara kültüründe multipl mikroorganizma saptanması FG’de mortalite için risk faktörleri olarak bulundu. Sonuç: İleri yaş, artmış FGSI skorları, artmış operasyon süresi, immünosüpresyon hastalığı olması, sistostomi yapılması, hastalığın abdominal yayılımının olması, mekanik ventilasyon ihtiyacı, yara kültüründe multipl mikroorganizma saptanmasının FG’si olan hastalarda mortaliteyi etkilediği düşünülmektedir.

🔖

Cite This Article

ÖZKAYA, M., ERÖZENCİ, A., ÇİTGEZ, S., DEMİRDAĞ, Ç., SELÇUK, B. (2022). Fournier’s Gangrene: Analysis of Risk Factors Affecting Mortality in a Tertiary Urology Referral Center. Journal of Urological Surgery, Cilt: 6 - Sayı: 3, 196–200. https://ajindex.com/articles/568695

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Smith G, Bunker C, Dinneen M. Fournier’s gangrene. Br J Urol 1998;81:347- 355
  2. Morais H, Neves J, Maciel Ribeiro H, Ferreira M, Guimarães N, Azenha N, Dias R, Fonseca A, Conceição L. Case series of Fournier’s gangrene: Affected body surface area: The un- derestimated prognostic factor. Ann Med Surg (Lond) 2017;16:19-22
  3. Eke N. Fournier’s gangrene: a review of 1726 cases. Br J Surg 2000;87:718- 728
  4. Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I, Mammen K. Fournier’s gangrene and its emergency management. Postgrad Med J 2006;82:516-519
  5. Yilmazlar T, Ozturk E, Alsoy A, Ozguc H. Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg 2007;31:1858- 1862
  6. Taviloglu K, Cabioglu N, Cagatay A, Yanar H, Ertekin C, Baspinar I, Ozsut H, Guloglu R. Idiopathic necrotizing fasciitis: risk factors and strategies for management. Am Surg 2005;71:315-320
  7. Norton KS, Johnson LW, Perry T, Perry KH, Sehon JK, Zi- bari GB. Management of Fournier’s gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Surg 2002;68:709-713
  8. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier’s gangrene. J Urol 1995;154:89-92
  9. Bozkurt O, Sen V, Demir O, Esen A. Evaluation of the utility of different scoring systems (FGSI, LRINEC and NLR) in the management of Fournier’s gangrene. Int Urol Nephrol 2015;47:243-248
  10. Baykal K, Albayrak S, Inal H, Elbuken E, Dündar K, Onol Y. Fournier’s disease: adjunctive hyperbaric oxygen therapy to classic therapy. Int J Urol 1996;3:161-162
  11. Chawla SN, Gallop C, Mydlo JH. Fournier’s gangrene: an analysis of repeated surgical debridement. Eur Urol 2003;43:572-575
  12. Jeong HJ, Park SC, Seo IY, Rim JS. Prognostic factors in Fournier gangrene. Int J Urol 2005;12:1041-1044
  13. Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I. Fournier’s gangrene: risk factors and strategies for management. World J Surg 2006;30:1750-1754
  14. Ozturk E, Ozguc H, Yilmazlar T. The use of vacuum assisted closure therapy in the management of Fournier’s gangrene. Am J Surg 2009;197:660-665.